These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 3021362

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A plasma inhibitor of sodium and potassium activated adenosine triphosphatase in patients with essential hypertension.
    Toriyabe S, Miura Y, Kimura S, Meguro Y, Sugawara T, Noshiro T, Takahashi M, Ohashi H, Sano N, Watanabe H.
    Tohoku J Exp Med; 1988 Jun; 155(2):129-37. PubMed ID: 2850642
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S, Fernandez PG, Longerich L, Gault H.
    Can J Cardiol; 1989 Jun; 5(5):249-54. PubMed ID: 2547501
    [Abstract] [Full Text] [Related]

  • 6. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF, Devynck MA, Elghozi JL, Kamal LA, Lacerda-Jacomini LC, Meyer P, Pernollet MG, Rosenfeld JB, De Thé H.
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [Abstract] [Full Text] [Related]

  • 7. Predominance of high molecular weight plasma Na(+)-K(+)-ATPase inhibitor in essential hypertension.
    Gonick HC, Weiler EW, Khalil-Manesh F, Weber MA.
    Am J Hypertens; 1993 Aug; 6(8):680-7. PubMed ID: 8217031
    [Abstract] [Full Text] [Related]

  • 8. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF, Crabos M, Grichois ML, Guicheney P, Meyer P.
    Klin Wochenschr; 1987 Aug; 65 Suppl 8():146-53. PubMed ID: 3037183
    [Abstract] [Full Text] [Related]

  • 9. Affinity chromatography for human Na+, K+-ATPase inhibitors in plasma and urine.
    Henning G, Cloix JF, Wainer IW, Pernollet MG, Devynck MA, Meyer P.
    Life Sci; 1985 May 06; 36(18):1787-98. PubMed ID: 2984510
    [Abstract] [Full Text] [Related]

  • 10. [Various properties of the Na+, K(+)-ATPase and the Mg (2+)-ATPase in erythrocytes from normotensive and hypertensive subjects].
    Canestrari F, Galli F, Gheller G, De Crescentini S, Biagiarelli B.
    Boll Soc Ital Biol Sper; 1991 Jul 06; 67(7):659-66. PubMed ID: 1667978
    [Abstract] [Full Text] [Related]

  • 11. (Na+ + K+) ATPase inhibitors and intracellular electrolytes in essential hypertension.
    Iwaoka T, Nugent CA, Umeda T, Sato T.
    Jpn Heart J; 1987 Sep 06; 28(5):695-705. PubMed ID: 2828706
    [Abstract] [Full Text] [Related]

  • 12. Measurement by bioluminescence technique of erythrocyte membrane Na+,K+-ATPase activity in hypertensive patients.
    Lechi C, Corradini P, Polignano R, Bonadonna G, Delva P, Lechi A.
    Clin Chim Acta; 1987 Mar 30; 163(3):329-37. PubMed ID: 3034452
    [Abstract] [Full Text] [Related]

  • 13. Ouabainlike Na+,K+-ATPase inhibitor in the plasma of normotensive and hypertensive humans and rats.
    de Wardener HE, Millett J, Holland S, MacGregor GA, Alaghband-Zadeh J.
    Hypertension; 1987 Nov 30; 10(5 Pt 2):I52-6. PubMed ID: 2824366
    [Abstract] [Full Text] [Related]

  • 14. Three red cell sodium transport systems in hypertensive and normotensive Utah adults.
    Smith JB, Ash KO, Hunt SC, Hentschel WM, Sprowell W, Dadone MM, Williams RR.
    Hypertension; 1984 Nov 30; 6(2 Pt 1):159-66. PubMed ID: 6327514
    [Abstract] [Full Text] [Related]

  • 15. [The activity and properties of Na,K-ATPase in the erythrocytes and the Na-pump inhibitor in the plasma of subjects with borderline arterial hypertension].
    Maslova MN, Ogorodnikova LE, Titkov IuS.
    Fiziol Zh SSSR Im I M Sechenova; 1991 Sep 30; 77(9):232-7. PubMed ID: 1666609
    [Abstract] [Full Text] [Related]

  • 16. Cytochemically assayable Na+,K+-ATPase inhibition by Milan hypertensive rat plasma.
    Holland S, Millett J, Alaghband-Zadeh J, de Wardener H, Ferrari P, Bianchi G.
    Hypertension; 1987 May 30; 9(5):498-503. PubMed ID: 3032790
    [Abstract] [Full Text] [Related]

  • 17. Abnormal Na+-K+ ATPase kinetics in a subset of essential hypertensive patients.
    de la Sierra A, Coca A, Aguilera MT, Urbano A.
    Eur J Clin Invest; 1988 Aug 30; 18(4):337-42. PubMed ID: 2844545
    [Abstract] [Full Text] [Related]

  • 18. Kinetic study of Na+-K+ pump in erythrocytes from essential hypertensive patients.
    Diez J, Hannaert P, Garay RP.
    Am J Physiol; 1987 Jan 30; 252(1 Pt 2):H1-6. PubMed ID: 3028158
    [Abstract] [Full Text] [Related]

  • 19. [Affinity chromatography for the detection of human endogenous inhibitor of NA+, K+ -ATPase].
    Henning G, Cloix JF.
    C R Seances Acad Sci III; 1983 Jan 30; 297(6):295-8. PubMed ID: 6318931
    [Abstract] [Full Text] [Related]

  • 20. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
    Tamura M, Lam TT, Inagami T.
    Biochemistry; 1988 Jun 14; 27(12):4244-53. PubMed ID: 2844224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.